Sunitinib in combination with mFOLFOX6 chemotherapy in patients with advanced solid tumors: A phase I study

被引：0
|
作者：
Leong, S.
Eckhardt, S.
Chan, E.
Chow, L.
VerMeulen, W.
Camidge, D.
Rothenberg, M.
Chow Maneval, E.
Chao, R.
Lockhart, A.
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Vanderbilt Univ, Med Ctr, Knoxville, TN USA
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII123 / VII123
页数：1
相关论文
共 50 条
  • [41] Cediranib in combination with mFOLFOX6: results from the cohort expansion phase of a two-part Phase I study
    LoRusso, P.
    Zalupski, M.
    Desai, S.
    Burris, H. A.
    Stella, P. J.
    Xu, J.
    Liu, Q.
    Mookerjee, B.
    Shields, A. F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 133 - 133
  • [42] Phase I study of AZD2171 in combination with oxaliplatin and infusional 5-FIJ (mFOLFOX6) in patients (pts) with advanced colorectal cancer (CRC)
    Chen, E.
    Jonker, D.
    Gauthier, I.
    MacLean, M.
    Wells, J.
    Powers, J.
    Robertson, J.
    Seymour, L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 113 - 113
  • [43] Sunitinib and bevacizumab in advanced solid tumors: A phase I trial
    Cooney, M. M.
    Garcia, J. A.
    Elson, P.
    Mekhail, T.
    Dreicer, R.
    Nock, C. J.
    Bokar, J. A.
    Tyler, A.
    Beatty, K.
    Bukowski, R. M.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] SUNITINIB IN COMBINATION WITH CARBOPLATIN (C) PLUS PACLITAXEL (P) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS (STS): PHASE I STUDY RESULTS
    Heath, E. I.
    Blumenschein, G. R.
    Cohen, R. B.
    LoRusso, P. Mucci
    LoConte, N.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [45] SAPPHIRE: A Randomized Phase II Study of mFOLFOX6
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (03) : 19 - 20
  • [46] Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer
    Taroh Satoh
    Kensei Yamaguchi
    Narikazu Boku
    Wataru Okamoto
    Tomotaka Shimamura
    Kentaro Yamazaki
    Xiaojin Shi
    Hideyuki Mishima
    Investigational New Drugs, 2012, 30 : 1511 - 1518
  • [47] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Countouriotis, A. M.
    Ruiz-Garcia, A.
    Soria, J. C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (07) : 993 - 1000
  • [48] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    E Boven
    C Massard
    J P Armand
    C Tillier
    V Hartog
    N M Brega
    A M Countouriotis
    A Ruiz-Garcia
    J C Soria
    British Journal of Cancer, 2010, 103 : 993 - 1000
  • [49] Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer
    Satoh, Taroh
    Yamaguchi, Kensei
    Boku, Narikazu
    Okamoto, Wataru
    Shimamura, Tomotaka
    Yamazaki, Kentaro
    Shi, Xiaojin
    Mishima, Hideyuki
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1511 - 1518
  • [50] Comparisons of effects of SOX and mFOLFOX6 chemotherapy regimens on patients with locally advanced gastric cancer
    Chen, Gui-Dong
    Cao, Bin-Xiao
    Shi, Ying
    Lv, Jie-Min
    Wang, Dong-Hai
    Shi, Lun-Bo
    JOURNAL OF CHEMOTHERAPY, 2022, 34 (02) : 117 - 122
12345